Evidence map›Paper›PMID 35116971›Full record

ArticleTranslational cancer research2019

Aggressive fibromatosis-associated with papillary thyroid cancer: two cases and a brief review.

Yao Li, Shichao Li, Xiaowei Qi, Wenying Fu, Fan Zhang, Xinhua Yang

Open access · diamondAbstract readCase Reports
In one paragraph

Article in Translational cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 66% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yao Li *Breast Disease Center, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China.
Shichao Li *Breast Disease Center, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China.
Xiaowei QiBreast Disease Center, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China.
Wenying FuBreast Disease Center, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China.
Fan ZhangBreast Disease Center, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China.
Xinhua YangBreast Disease Center, Southwest Hospital, Third Military Medical University, Chongqing, 400038, China.
Army Medical University · CNSouthwest Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aggressive fibromatosis (AF) is usually considered a benign tumor. Reports of the association between AF and malignancies have appeared infrequently. Herein, we report two cases of AF arising in the neck that were associated with papillary thyroid cancer. Two cases are presented in this article. One is a 31-year-old male patient who was diagnosed with AF 9 months after his thyroid cancer operation; there has been no recurrence after surgical resection and postoperative radiotherapy. The other is a 53-year-old female patient who was diagnosed with thyroid cancer and AF simultaneously. There is still no recurrence after surgical resection, endocrine therapy and thyroid-stimulating hormone (TSH) suppression treatment. Both cases showed β-catenin positivity upon further immunohistochemistry (IHC) examination. AF is a rare and benign tumor. It can occur in association with malignancies, such as thyroid cancer. Whether a patient diagnosed with AF associated with thyroid cancer has a family history of a familial adenomatous polyposis (

Indexed as

Aggressive fibromatosis (AF)CTNNB1 genefamilial adenomatous polyposis (FAP) gene mutationthyroid cancerβ-catenin mutation

Identifiers

PMID35116971
PMCPMC8798143
OpenAlexW4229667182

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.